Helix Acquisition Corp. III is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands. The company has no active business operations and generates no operating revenue, as its sole purpose is to identify and acquire a private company to take public. While the SPAC is permitted to pursue a business combination in any industry, its strategic focus is on the healthcare sector, specifically targeting companies in the biotechnology, medical technology, and life sciences industries. The company is sponsored by Helix Holdings III LLC, an affiliate of the healthcare-focused investment firm Cormorant Asset Management. In January 2026, Helix Acquisition Corp. III completed its initial public offering on the Nasdaq, raising $172.5 million. These proceeds are held in a trust account and will be used to fund a future business combination, which the company has 24 months to complete from the time of its IPO.
We couldn't find any ticker for HLXC. Please check if the ticker was entered correctly—or if it is listed. If not, we don't have any data for that asset at the moment :(
...and much more!